Examkin

Question

Difficulty: MediumGynecologic Oncology

A 61-year-old woman, gravida 3, para 3, presents to the gynecology clinic reporting a three-day history of light vaginal spotting. Her last menstrual period occurred 10 years ago, and she denies any postmenopausal bleeding prior to this episode. Her medical history is significant for type 2 diabetes mellitus, chronic hypertension, and obesity (BMI 38 kg/m^2). Current medications include metformin, lisinopril, and a daily multivitamin. Vital signs are within normal limits. Pelvic examination demonstrates pale, thinned vaginal mucosa with decreased rugosity. A small amount of dark blood is visible at the external cervical os. Bimanual examination reveals a normal-sized, mobile uterus without adnexal masses. A transvaginal ultrasound reveals an endometrial echo complex measuring 9 mm in thickness. Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial tissue samplingAnswer
  2. B
    Routine follow-up with repeat ultrasonography in 6 months
  3. C
    Initiation of local vaginal estrogen therapy
  4. D
    Total extrafascial hysterectomy and bilateral salpingo-oophorectomy
  5. E
    Empirical treatment with cyclic oral progestins

Answer

The correct answer is Endometrial tissue sampling.
The correct answer is endometrial tissue sampling. Any postmenopausal woman presenting with vaginal bleeding requires prompt evaluation to rule out endometrial carcinoma. The initial workup typically involves a transvaginal ultrasound (TVUS). In a postmenopausal patient with bleeding, an endometrial echo complex (stripe) thickness of ≤\leq 4 mm has a high negative predictive value for malignancy, and tissue sampling can often be deferred. However, this patient has an endometrial thickness of 9 mm, which is markedly abnormal. Furthermore, she possesses classic risk factors for estrogen-dependent (Type I) endometrial cancer, including obesity, type 2 diabetes, and advanced age. Peripheral aromatization of androgens in adipose tissue leads to chronic, unopposed estrogen exposure, causing endometrial proliferation. The definitive next step is histologic evaluation of the uterine lining to diagnose or exclude atypical hyperplasia or carcinoma.

Step-by-Step Solution

1
Identify the primary clinical problem and patient demographic.
The patient is a 61-year-old postmenopausal woman presenting with new-onset vaginal bleeding.
Postmenopausal bleeding is considered a cardinal sign of endometrial carcinoma until proven otherwise.
2
Evaluate the patient's risk factors for the suspected disease.
The patient has multiple risk factors for type I endometrial cancer: advanced age, obesity (BMI 38 kg/m^2), and type 2 diabetes mellitus.
Obesity causes increased peripheral conversion of androgens to estrone by adipose tissue aromatase, leading to chronic unopposed estrogen exposure.
3
Interpret the diagnostic imaging findings in the context of the clinical presentation.
Transvaginal ultrasound reveals an endometrial thickness of 9 mm.
In a postmenopausal woman with vaginal bleeding, an endometrial stripe greater than 4 mm is abnormal and warrants histologic evaluation.
4
Determine the definitive next step in management.
The patient requires immediate histologic evaluation via endometrial tissue sampling.
To definitively rule out endometrial hyperplasia or carcinoma, tissue must be obtained for pathologic review before any medical or definitive surgical treatment is initiated.

Key Concept

Evaluation of Postmenopausal Bleeding
Rate this question

Topics

Gynecologic Oncology

More questions from this topic